Markedsdata leveret af TwelveData og Morningstar
Cuprina Holdings (Cayman) Limited is a biomedical and biotechnology company focused on developing and commercializing products for chronic wound management, infertility, medical waste recycling, and cosmeceuticals. The company’s product portfolio includes medical-grade sterile blowfly larvae bio-dressings used for biological debridement in wound care, alongside other specialty wound treatment solutions and biomaterial-based products. Cuprina also works with healthcare and wellness applications that combine clinical utility with nature-derived or sustainable inputs. Based in Singapore and incorporated in the Cayman Islands, Cuprina Holdings (Cayman) Limited serves markets in medical devices, wound care, and health and beauty, positioning itself as a niche participant in specialty biomedical products.